Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A Model of Population and Subject (MOPS) Intensities with Application to Multiple Sclerosis Lesion Segmentation.
Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination.
Estimating the marginal effect of socioeconomic factors on the demand of specialty drugs.
The Severity of Bowel Dysfunction in Patients with Neurogenic Bladder.
Benign Multiple Sclerosis is Associated with Reduced Thinning of the Retinal Nerve Fiber and Ganglion Cell Layers in Non-Optic-Neuritis Eyes.
Pushing the boundaries of neuromyelitis optica: Does antibody make the disease?
Normatization of the symbol digit modalities test-oral version in a latin american country.
The right-to-die campaigner who won a key legal ruling.
Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS). (REFINE)
Multiple sclerosis: getting personal with induced pluripotent stem cells.
Longitudinal associations between MRI and cognitive changes in very early MS.
Heart rate variability.
Internal jugular vein blood flow in multiple sclerosis patients and matched controls.
B cells in MS and NMO: pathogenesis and therapy.
The Inflammasome Pyrin Contributes to Pertussis Toxin-Induced IL-1β Synthesis, Neutrophil Intravascular Crawling and Autoimmune Encephalomyelitis.
Immunophenotype of mouse cerebral hemispheres-derived neural precursor cells.
Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis.
Localized grey matter atrophy in multiple sclerosis: A meta-analysis of voxel-based morphometry studies and associations with functional disability.
[Progressive multifocal leukoencephalopathy as a complication of natalizumab therapy].
Risk of fractures in patients with multiple sclerosis: A population-based cohort study.
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study.
Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course.
Association between smoking and cognitive impairment in multiple sclerosis.
Neurogenic vision loss: Causes and outcome. An experience from a tertiary center in Northern India.
Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP).
Pages
« first
‹ previous
…
521
522
523
524
525
526
527
528
529
…
next ›
last »